¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"compound specificity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigenic specificity
    Ç׿øÆ¯À̼º
  • diagnostic specificity
    Áø´ÜƯÀ̼º
  • ethnic specificity
    ÀÎÁ¾Æ¯À̼º
  • host specificity
    ¼÷ÁÖÆ¯À̼º
  • organ specificity
    ±â°üƯÀ̼º, Àå±âƯÀ̼º
  • species specificity
    Á¾Æ¯À̼º
  • specificity
    1. ƯÀ̼º 2. Ư¼ö¼º
  • strain specificity
    ÁÖÆ¯À̼º
  • aromatic compound
    ¹æÇâÁ·È­ÇÕ¹°
  • asymmetric compound
    ºñ´ëĪȭÇÕ¹°
  • acyclic compound
    ¹«°í¸®È­ÇÕ¹°
  • addition compound
    ÷°¡È­ÇÕ¹°
  • adsorption compound
    ÈíÂøÈ­ÇÕ¹°
  • aliphatic compound
    Áö¹æÁ·È­ÇÕ¹°
  • amphoteric compound
    ¾ç¼ºÈ­ÇÕ¹°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • compound
    º¹Àâ, º¹ÇÕ, È­ÇÕ¹°
  • organic compound
    À¯±âÈ­ÇÕ¹°
  • compound nevus
    º¹ÇÕ¸ð¹Ý
  • specificity
    ƯÀ̼º
  • antigenic specificity
    Ç׿øÆ¯À̼º
  • organ specificity
    ±â°üƯÀ̼º, Àå±âƯÀ̼º
  • species specificity
    Á¾Æ¯À̼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • compound specificity
    È­ÇÕ¹°Æ¯À̼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigenic specificity
    Ç׿øÆ¯À̼º
  • carrier specificity
    ³ª¸£°³Æ¯À̼º, ¸Å°³Æ¯À̼º, ¿î¹ÝüƯÀ̼º
  • diagnostic specificity
    Áø´ÜÀûƯÀ̼º
  • ethnic specificity
    ÀÎÁ¾ÀûƯÀ̼º
  • host specificity
    ¼÷ÁÖÆ¯À̼º
  • host-parasite specificity
    ¼÷ÁÖ±â»ýÃæÆ¯À̼º
  • organ specificity
    ±â°üƯÀ̼º, Àå±âƯÀ̼º
  • public specificity
    ±ºÁýƯÀ̼º, °øµ¿Æ¯À̼º
  • specificity
    ƯÀ̼º
  • species specificity
    Á¾Æ¯À̼º
  • strain specificity
    ÁÖÆ¯À̼º
  • type specificity
    ÇüƯÀ̼º
  • acyclic compound
    ¹«°í¸®È­ÇÕ¹°
  • addition compound
    ÷°¡È­ÇÕ¹°
  • adsorption compound
    ÈíÂøÈ­ÇÕ¹°
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigenic specificity
    Ç׿øÆ¯À̼º(ù÷ê«÷åì¶àõ).
  • public specificity
    °øµ¿Æ¯À̼º
  • acyclic compound
    ºñȯ»óÈ­ÇÕ¹°.
  • addition compound
    ÷°¡È­ÇÕ¹°(ôÕÊ¥ ûùùêÚª).
  • adsorption compound
    ÈíÂøÈ­ÇÕ¹°.
  • aliphatic compound
    Áö¹æÁ·È­ÇÕ¹°.
  • amino compound
    ¾Æ¹Ì³ëÈ­ÇÕ¹°(¡­ûùùêÚª).
  • amphoteric compound
    ¾ç¼ºÈ­ÇÕ¹°(¡­ûùùêÚª).
  • antimuscarinic compound
    Ç×¹«½ºÄ«¸°Á¦.
  • aromatic compound
    ¹æÇâÁ·È­ÇÕ¹°.
  • heme compound
    ÇðÈ­ÇÕ¹°
  • heterocyclic compound
    ÇìÅ×·Î°í¸®È­ÇÕ¹°, ÀÌÁ¾¿øÀÚ°í¸®È­ÇÕ¹°.
  • heteropolar compound
    ÀÌ(¼º)±ØÈ­ÇÕ¹°(ì¶àõпûùùêÚª).
  • homeopolar compound
    µ¿±ØÈ­ÇÕ¹°.
  • homocyclic compound
    µ¿¼Òȯ½ÄÈ­ÇÕ¹°.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • compound specificity
    È­ÇÕ¹°Æ¯À̼º(ûùùêÚª÷åì¶àõ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigenic specificity
    Ç׿øÆ¯À̼º(ù÷ê«÷åì¶àõ).
  • carrier specificity
    ¿î¹ÝüƯÀ̼º
  • diagnostic specificity
    Áø´ÜÀû ƯÀ̵µ
  • ethnic specificity
    ÀÎÁ¾(¹ÎÁ·)Àû ƯÀ̼º
  • organ specificity
    ±â°ü<Àå±â>ƯÀ̼º (¡­÷åì¶àõ).
  • organ specificity
    ±â°ü<Àå±â>ƯÀ̼º (Ðïί<íóÐï>÷åì¶àõ)
  • public specificity
    °øµ¿Æ¯À̼º
  • species specificity
    Á¾Æ¯À̼º(ðú÷åì¶àõ).
  • specificity
    ƯÁ¤¼º(÷åïÒàõ)
  • specificity
    ƯÀ̼º
  • specificness =specificity
    ƯÀ̵µ,ƯÀ̼º.
  • type specificity
    ÇüƯÀ̼º
  • acyclic compound
    ºñȯ»óÈ­ÇÕ¹°.
  • addition compound
    ÷°¡È­ÇÕ¹°(ôÕÊ¥ ûùùêÚª).
  • adsorption compound
    ÈíÂøÈ­ÇÕ¹°.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Compound gland
    º¹ÇÕ»ù
    [¿¾ ¿ë¾î] º¹ÇÕ¼±
  • Compound intercellular junction
    º¹ÇÕ¼¼Æ÷»çÀÌ¿¬Á¢
    [¿¾ ¿ë¾î] º¹ÇÕ¼¼Æ÷°£°áÇÕ[¿¬Á¢]
  • Compound intercellular junction
    º¹ÇÕ¼¼Æ÷»çÀÌ¿¬Á¢
    [¿¾ ¿ë¾î] º¹ÇÕ¼¼Æ÷¿¬Á¢
  • Compound joint
    º¹ÇÕ°üÀý
    [¿¾ ¿ë¾î] º¹°üÀý
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carbamate compound
    Ä«¹Ù¸ÞÀÌÆ®°è »ìÃæÁ¦
  • chlorinated hydrocarbon compound
    À¯±â¿°¼Ò°è»ìÃæÁ¦
  • host specificity
    ¼÷ÁÖÆ¯À̼º
  • host-parasite specificity
    ¼÷ÁÖ±â»ýÃæÆ¯À̼º
  • organ specificity
    ±â»ýÀå±âƯÀ̼º
  • organophosphorus compound
    À¯±âÀΰè»ìÃæÁ¦
  • pyrethroid compound
    ÇÇ·¹½º·ÎÀ̵å°è»ìÃæÁ¦
  • species specificity
    Á¾Æ¯À̼º
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • absolute specificity
    Àý´ëƯÀ̼º (ï¾Óß÷åì¶àõ)
  • antibody specificity
    Ç×ü ƯÀ̼º(ù÷ô÷÷åì¶àõ)
  • base specificity
    ¿°±âƯÀ̼º(ç¤Ðñ÷åì¶àõ)
  • enzyme specificity
    È¿¼ÒƯÀ̼º(ý£áÈ÷åì¶àõ)
  • group specificity
    ±â(Ðñ) ƯÀ̼º(÷åì¶àõ)
  • sequece specificity
    ¼­¿­Æ¯À̼º(ßíÖª÷åì¶àõ)
  • specificity
    ƯÀ̼º(÷åì¶àõ)
  • specificity constant
    ƯÀ̼º »ó¼ö(÷åì¶àõßÈâ¦)
  • specificity factor
    ƯÀ̼º ÀÎÀÚ(÷åì¶àõì×í­)
  • alicyclic compound
    ºñ(Þª)°í¸®Çü(û¡)È­ÇÕ¹°(ûùùêÚª)
  • anticancer compound
    Ç×¾ÏÈ­ÇÕ¹°(ù÷äßûùùêÚª)
  • antithyroid compound
    Ç×°©»ó¼± È­ÇÕ¹°(ù÷Ë£ßÒàÍûùùêÚª)
  • azo compound
    ¾ÆÁ¶È­ÇÕ¹°(ûùùêÚª)
  • carbamino compound
    Ä«¸£¹Ù¸¶À̵å È­ÇÕ¹°(ûùùêÚª)
  • compound
    È­ÇÕ¹°(ûùùêÚª)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • specificity
    ƯÀ̼º, ƯÀ̵µ
  • compound
    È­ÇÕ¹°, ÄÄÆÄ¿îµå
  • compound scan
    º¹ÇÕ½ºÄµ
  • compound scan motion
    º¹ÇÕ½ºÄµ¿îµ¿
  • compound sector
    º¹ÇÕ ºÎä²Ã
  • contact compound scan
    Á¢Ã˺¹ÇÕ½ºÄµ
  • inorganic compound
    ¹«±âÈ­ÇÕ¹°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SPEC specificity
PCC Pasteur Culture Collection; percutaneous cecostomy; pheochromocytoma; phosphate carrier compound; pl...
ALEC artificial lung-expanding compound
CAP camptodactyly-arthropathy-pericarditis [syndrome]; Canada Assistance Plan; capsule; captopril; catab...
CC calcaneal-cuboid; calcium cyclamate; cardiac catheterization; cardiac contusion; cardiac cycle; card...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CPSF Cleavage and polyadenylation specificity factor
SP Specificity
SPEC specificity
C 48/80 Compound 48/80
CAP Compound Action Potential
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • compound specificity
    È­ÇÕ¹° ƯÀ̼º
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • antigenic specificity
    Ç׿ø ƯÀ̼º
  • carrier specificity
    ¿î¹Ýü ƯÀ̼º
  • addition compound
    ÷°¡ È­ÇÕ¹°
    µÎ °³ ÀÌ»óÀÇ È­ÇÕ¹°, ȤÀº ¿ø¼ÒÀÇ °áÇÕ¿¡ ÀÇÇØ¼­ »ý±ä È­ÇÕ¹°.
  • adsorption compound
    ÈíÂø È­ÇÕ¹°
  • antimuscarinic compound
    Ç×¹«½ºÄ«¸°Á¦
  • aromatic compound
    ¹æÇâÁ· È­ÇÕ¹°
  • chain compound
    »ç½½ È­ÇÕ¹°
  • compound action potential
    º¹ÇÕ È°µ¿ Àü¾Ð
  • compound anchorage
    º¹ÇÕ °íÁ¤
    µÎ °³ ȤÀº ±× ÀÌ»óÀÇ Ä¡¾Æ·ÎºÎÅÍ ÀúÇ×À» ¹Þ´Â ±³Á¤ °íÁ¤.
  • compound cavity
    º¹ÇÕ ¿Íµ¿
    óġµÈ »óÅ¿¡¼­ Ä¡¾ÆÀÇ 2¸éÀÌ Ä§½ÀµÈ ¿ì½Ä º´¼Ò.
  • compound composite odontoma
    º¹ÇÕ¼º Ä¡¾ÆÁ¾, ÁýÇÕ¼º Ä¡¾ÆÁ¾
  • compound dislocation
    º¹Àâ Å»±¸
  • compound gland
    º¹ÇÕ »ù, º¹ÇÕ¼±
    ºÐºñ °üÀÌ °¡Áö¸¦ ³½´Ù. ºÐºñ ´ÜÀ§´Â È¥ÇÕÇüÀ¸·Î, °ü»ó Æ÷»ó »ùÀ̶ó´Â ¿ë¾î°¡ »ç¿ëµÈ´Ù.
  • compound nevus
    º¹ÇÕ¼º ¸ð¹Ý, º¹ÇÕ ¸ð¹Ý
  • compound S
    º¹ÇÕü S
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
analytical specificity Freedom from interference by any element or compound other than the analyte.
(05 Mar 2000)
antibody specificity The property of antibodies which enables them to react with some antigenic determinants and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site.
(12 Dec 1998)
biological specificity <biology, zoology> The specific, orderly patterns of development and metabolism which define and characterise an individual and its species.
(21 Mar 1998)
relative specificity The specificity of a medical screening test as determined by comparison with the same type of test (e.g., specificity of a new serological test relative to specificity of an established serological test).
(05 Mar 2000)
sensitivity and specificity Measures for assessing the results of diagnostic and screening tests. Sensitivity represents the proportion of truly diseased persons in a screened population who are identified as being diseased by the test. It is a measure of the probability of correctly diagnosing a condition. Specificity is the proportion of truly nondiseased persons who are so identified by the screening test. It is a measure of the probability of correctly identifying a nondiseased person.
(12 Dec 1998)
species specificity Restriction of a characteristic or response to the members of one species; it usually refers to that property of the immune response which differentiates one species from another on the basis of antigen recognition, but the concept is not limited to immunology and is used loosely at levels higher than the species.
(12 Dec 1998)
specificity The ability of the immune response to interact with individual antigens.
(09 Oct 1997)
specificity constant Ratio of the maximum velocity (Vmax) or kcat to the true Km value for a specific substrate in an enzyme-catalyzed reaction.
(05 Mar 2000)
substrate specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts.
(12 Dec 1998)
diagnostic specificity The probability (P) that, given the absence of disease (D), a normal test result (T) excludes disease; i.e., P(T/D).
(05 Mar 2000)
organ specificity Restriction of a characteristic or response to a particular organ of the body; it usually refers to that property of the immune response which differentiates one organ from another on the basis of antigen recognition, but the concept is not limited to immunology.
(12 Dec 1998)
acetone compound <biochemistry> Any of the three compounds created by acetyl coenzyme A (acetoacetate, hydroxybutyrate, and acetone) which are water-soluble cellular fuels normally exported by the liver.
They can build up in the blood and body tissues because of starvation, untreated diabetes mellitus, or other disorders that interfere with carbohydrate metabolism. The body rids itself of ketones mainly through urine, but it rids itself of acetone through the lungs, which gives the breath a characteristic fruity odour. If ketones build up in the body long enough, they cause serious illness and coma (see ketoacidosis.)
(09 Oct 1997)
acyclic compound An organic compound in which the chain does not form a ring.
Synonym: aliphatic compound, open chain compound.
(05 Mar 2000)
addition compound Strictly, a complex of two or more complete molecules in which each preserves its fundamental structure and no covalent bonds are made or broken (e.g., hydrates of salts, adducts), loosely, association of acids with basic organic compound's (e.g., amines with HCl), more loosely, addition of two molecules without loss of any atom, but forming new covalent bonds (e.g., CH2==CH2 + Br2 &rarr; BrCH2-CH2Br).
(05 Mar 2000)
aliphatic compound An organic compound in which the chain does not form a ring.
Synonym: aliphatic compound, open chain compound.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • specificity
    Ư¼º;ƯÀ̼º;ÇÑÁ¤¼º
  • compound
    À» ÇÕ¼ºÇÏ´Ù
  • compound
    ÇÕ¼ºÀÇ;È¥¼ºÀÇ;º¹ÇÕÀÇ;º¹ÀâÇÑ;º¹½ÄÀÇ;È­ÇÕÇÑ;ÁýÇÕÀÇ;(¹®ÀåÀÌ)Áß¹®ÀÇ;(³¹¸»ÀÌ)º¹ÇÕÀÇ;(ÀúÅÃ.°øÀåÀÇ)¿ï¾È;±¸³»;È¥ÇÕ¹°;ÇÕ¼º¹°;È­ÇÕ¹°;º¹ÇÕ¾î;ÇÕ¼º¾î;(¿ä¼Ò.¼ººÐµîÀ»)È¥ÇÕÇÏ´Ù;ÇÕ¼ºÇÏ´Ù;(¾à µîÀ»)Á¶Á¦ÇÏ´Ù;¼¯¾î¼­ ¸¸µé´Ù;(ÀÏÀ»)È­ÇØ½ÃŰ´Ù;À̾߱â·Î ÇØ°áÁþ´Ù;»çÈ­ÇÏ°Ô ÇÏ´Ù;(°è
  • compound E
    º¹ÇÕ E¹°Áú
  • compound engine
    º¹½Ä ±â°ü;2´Ü ÆØÃ¢±â°ü
  • compound eye
    º¹¾È;°ã´«
  • compound flower
    µÎ»óÈ­;°ã²É(±¹È­°ú ½Ä¹°µîÀÇ)
  • compound fraction
    COMPLEX FRACTION
  • compound fracture
    °³¹æ °ñÀý
  • compound fruit
    °ã¿­¸Å;º¹°ú 
  • compound householder
    Áö¹æ¼¼´Â ÁÖÀÎÀÌ ¹°±â·Î ÇÏ°í ¼¼µç »ç¶÷
  • compound interest
    º¹¸®
  • compound interval
    º¹ÇÕÀ½Áú
  • compound leaf
    °ãÀÙ;º¹¿±
  • compound microscope
    º¹ÇÕÇö¹Ì°æ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á